Don't disagree, but LH (and to a large extent cancers as well) are a mixed bag, they've made it clear they recognize the need to look deeper than the diagnosis and see what's going on at the molecular level, and they've designed that into the protocols both with cancers and LH.

At some point the sponsored studies will come.. unfortunately probably after a resoundingly obvious trial success, but that's where I see the bulk of the research coming from.